BioCentury
ARTICLE | Clinical News

AKB-9778: Phase I started

December 5, 2011 8:00 AM UTC

Akebia began a U.S. Phase I trial to evaluate single ascending-doses of AKB-9778 in up to 48 healthy volunteers. ...